恩佩罗工业 NPO 深 沪
已收盘 01-30 16:00:00 美东时间
238.78
-1.220
-0.51%
华盛通- 最 高241.55
- 今 开236.42
- 成交量 21.43万股
- 最 低 234.895
- 昨 收 240.00
- 总市值 50.27亿
- 52周最高 248.565
- 市盈率 静 69.11
- 换手率 1.02%
- 52周最低 132.57
- 委 比 -85.19%
- 总股本 2105.35万
- 历史最高 248.565
- 量 比 1.36
- 振 幅 2.77%
- 历史最低 15.90
- 每 手 1
- 风险率 26.11%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Gabelli Funds Hosts Annual Pump, Valve, and Water Systems Symposium
Gabelli Funds Hosts Annual Pump, Valve, and Water Systems Symposium Gabelli Funds, LLC will host its 36th Annual Pump, Valve, and Water Systems Symposium on Thursday, February 26th, 2026, at Convene 530 Fifth Avenue in New York, NY. The event will feature discussions with leading companies across th
01-28 01:20
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
Keybanc Maintains Overweight on Enpro, Raises Price Target to $260
Keybanc analyst Jeffrey Hammond maintains Enpro (NYSE:NPO) with a Overweight and raises the price target from $250 to $260.
01-26 21:44
美股大行评级 | 麦格理首予哔哩哔哩"跑赢大市"评级，目标价36.03美元； 高盛首予联合健康集团"买入"评级，目标价406美元
今日重点评级关注：摩根士丹利：上调Alvotech评级至"超配"，目标价14美元；蒙特利尔银行：维持PG&E"跑赢大市"评级，目标价从23美元升至25美元
2025-10-15 18:20
Enpro将收购两家企业
美股周一早盘，精密工业制造解决方案提供商Enpro（NPO）上涨3.1%，此前该公司宣布将以2.8亿美元收购AlpHa Measurement Solut...
2025-10-13 22:41
Oppenheimer Maintains Outperform on Enpro, Raises Price Target to $240
Oppenheimer analyst Ian Zaffino maintains Enpro (NYSE:NPO) with a Outperform and raises the price target from $215 to $240.
2025-08-06 20:15
Enpro Raises FY2025 Adj EPS Guidance from $7.00-$7.70 to $7.60-$8.10 vs $7.41 Est
Enpro (NYSE:NPO) raises FY2025 Adj EPS guidance from $7.00-$7.70 to $7.60-$8.10 vs $7.41 analyst estimate..
2025-08-05 18:32
Enpro Q2 Adj. EPS $2.03 Misses $2.10 Estimate, Sales $288.100M Beat $283.833M Estimate
Enpro (NYSE:NPO) reported quarterly earnings of $2.03 per share which missed the analyst consensus estimate of $2.10 by 3.2 percent. This is a 2.4 percent decrease over earnings of $2.08 per share from the same period
2025-08-05 18:31
美股大行评级 | 潜在涨幅147.43%！HC Wainwright & Co.上调Pacira BioSciences目标价至65美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116650478822592513.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Pacira BioSciences(PCRX)"买入"评级，目标价从48美元升至65美元</p> <p>• 瑞穗：上调Amylyx Pharmaceuticals(AM
2025-04-09 08:50
EnPro Industries Highlights Strong Sealing Technologies Amid Challenges
Enpro Industries, Inc. (($NPO)) has held its Q4 earnings call. Read on for the ...
2025-02-20 08:18
